These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2849912)

  • 21. Theiler's murine encephalomyelitis virus neutralization escape mutants have a change in disease phenotype.
    Roos RP; Stein S; Routbort M; Senkowski A; Bodwell T; Wollmann R
    J Virol; 1989 Oct; 63(10):4469-73. PubMed ID: 2476574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the immune response to intracerebral inoculation of Theiler's murine encephalomyelitis virus: fine protein specificity of the splenic T cell and humoral antibody response.
    Scheu AK; Cuesta A; Rubio N
    Immunol Lett; 1989 May; 21(2):171-6. PubMed ID: 2548954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hierarchy of effects of the MHC and T cell receptor beta-chain genes in susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Kappel CA; Dal Canto MC; Melvold RW; Kim BS
    J Immunol; 1991 Dec; 147(12):4322-6. PubMed ID: 1836484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the humoral immune response in resistance to Theiler's virus infection.
    Rossi CP; Cash E; Aubert C; Coutinho A
    J Virol; 1991 Jul; 65(7):3895-9. PubMed ID: 1645797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Receptors for Theiler's murine encephalomyelitis virus: characterization by using rabbit antiviral antiserum.
    Rubio N; Cuesta A
    J Virol; 1988 Nov; 62(11):4303-6. PubMed ID: 2845143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of B lymphocytes present in the demyelinating lesions induced by Theiler's virus.
    Cash E; Bandeira A; Chirinian S; Brahic M
    J Immunol; 1989 Aug; 143(3):984-8. PubMed ID: 2545781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibody defines determinant between Theiler's virus and lipid-like structures.
    Fujinami RS; Zurbriggen A; Powell HC
    J Neuroimmunol; 1988 Nov; 20(1):25-32. PubMed ID: 2460501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of restricted predominant epitopes of Theiler's murine encephalomyelitis virus capsid proteins expressed in the lambda gt11 system: differential patterns of antibody reactivity among different mouse strains.
    Crane MA; Jue C; Mitchell M; Lipton H; Kim BS
    J Neuroimmunol; 1990 May; 27(2-3):173-86. PubMed ID: 1692032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the TO strains of Theiler's mouse encephalomyelitis viruses.
    Lipton HL
    Infect Immun; 1978 Jun; 20(3):869-72. PubMed ID: 208981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus.
    Paya CV; Patick AK; Leibson PJ; Rodriguez M
    J Immunol; 1989 Jul; 143(1):95-102. PubMed ID: 2543704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization and specificity of humoral immune responses to Theiler's murine encephalomyelitis virus capsid proteins.
    Clatch RJ; Pevear DC; Rozhon E; Roos RP; Miller SD; Lipton HL
    J Gen Virol; 1987 Dec; 68 ( Pt 12)():3191-6. PubMed ID: 2826657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The antibody response in Theiler's virus infection: new perspectives on multiple sclerosis.
    Ohara Y; Roos R
    Prog Med Virol; 1987; 34():156-79. PubMed ID: 2821576
    [No Abstract]   [Full Text] [Related]  

  • 33. IgG subclass responses to Theiler's murine encephalomyelitis virus infection and immunization suggest a dominant role for Th1 cells in susceptible mouse strains.
    Peterson JD; Waltenbaugh C; Miller SD
    Immunology; 1992 Apr; 75(4):652-8. PubMed ID: 1350571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal anti-I-A antibody reverses chronic paralysis and demyelination in Theiler's virus-infected mice: critical importance of timing of treatment.
    Friedmann A; Frankel G; Lorch Y; Steinman L
    J Virol; 1987 Mar; 61(3):898-903. PubMed ID: 3492612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coexpression of class I major histocompatibility antigen and viral RNA in central nervous system of mice infected with Theiler's virus: a model for multiple sclerosis.
    Lindsley MD; Patick AK; Prayoonwiwat N; Rodriguez M
    Mayo Clin Proc; 1992 Sep; 67(9):829-38. PubMed ID: 1434926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of T cell receptor V beta genes in Theiler's virus-induced demyelination of mice.
    Rodriguez M; Patick AK; Pease LR; David CS
    J Immunol; 1992 Feb; 148(3):921-7. PubMed ID: 1309845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus.
    Lindsley MD; Rodriguez M
    J Immunol; 1989 Apr; 142(8):2677-82. PubMed ID: 2495323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Partial suppression of Theiler's virus-induced demyelination in vivo by administration of monoclonal antibodies to immune-response gene products (Ia antigens).
    Rodriguez M; Lafuse WP; Leibowitz J; David CS
    Neurology; 1986 Jul; 36(7):964-70. PubMed ID: 3487048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in genetically resistant mice.
    Olsberg C; Pelka A; Miller S; Waltenbaugh C; Creighton TM; Dal Canto MC; Lipton H; Melvold R
    Reg Immunol; 1993; 5(1):1-10. PubMed ID: 8347465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Theiler's virus encephalomyelitis is unaffected by treatment with myelin components.
    Lang W; Wiley C; Lampert P
    J Neuroimmunol; 1985 Jul; 9(1-2):109-13. PubMed ID: 4008634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.